UARU
Ваш акаунт не активовано. Перевірте пошту. 
  1. Робота в Україні
  2. Компанії
  3. Робота і вакансії в Saccade Diagnostics в Україні

Saccade Diagnostics

 Заблокована Перевірено
На сайті з 6 грудня 2018

Опис компанії

Saccade Diagnostics is a multiple award winning spin out of the University of Aberdeen focused on developing eye movement tests as a Point of Care diagnostic tool (SaccScan) to assist clinical assessment, referrals and management of different psychiatric disorders at the level of the individual patient.

Mental ill health is now recognised as the largest cause of short and long term disability worldwide costing the global economy US$2.5T in 2010 (€798 billion in Europe), with a projected increase to over US$6T by 2030, a CAGR of 7.0%. 1 in 5 of us experience mental health problems during our lifetime but more than half of patients don’t receive adequate care at first presentation of illness. Treatments are available that allow patients to resume normal functioning in society but clinicians are struggling to make accurate diagnosis, match therapy to condition, and provide timely care. Currently, when patients’ symptoms and behaviour don’t meet the criteria set out in the diagnostic manual, it may take up to 10 years to diagnose the illness. Delays in receiving a diagnosis can significantly impede delivery of the most effective treatment plan, exposing the patient to risk of further deterioration in well-being, reduction in quality of life leading to job loss, family breakdown, and self-harming.

SaccScan has been demonstrated to detect schizophrenia with better than 95% accuracy and has been extended with the same precision to bipolar disorder and major depression illnesses. The test can be performed within 30 to 45 minutes and results produced over the internet at near real-time speed. Built on existing eye tracking technology, and access to proprietary clinical reference databases, SaccScan successfully utilises eye movement abnormalities as clinical diagnostic biomarkers for serious mental illnesses. Early economic modelling showed that introducing SaccScan into health care services could produce savings of €40k per patient in the case of suspected schizophrenia alone.

We are backed by the Wellcome Trust (the largest biomedical research charity in the world), the Department of Health (responsible for administering the NHS - the largest healthcare system in the world) and several other agencies including the European Commission through H2020. We are partnered with world leading companies in their fields within the supply chain. We are collaborating with multiple field validation sites on an international scale who will provide the necessary test bed environment to validate our prototypes in addition to current longitudinal clinical studies across labs in Scotland between Aberdeen, Glasgow and Edinburgh.

Вакансії в Saccade Diagnostics

У цієї компанії на даний момент немає активних вакансій.

Часто шукають

↑ Вгору